Learn about essential IP strategies for healthcare spin-outs, focusing on how tailored approaches for biotech, pharma, and digital health innovations can ensure long-term success.
Fourth webinar in the series: From research and innovation to development: how to plan and execute translational projects in life sciences, this edition looks more closely at IP protection strategies for translational research.
It focuses on intellectual property (IP) and spin-out strategies in the human healthcare sector. A well-designed IP strategy, tailored to the type of innovation, is crucial for the long-term success of university spin-outs.
Join experts Sara Holland, Dave Holt, and Elisabeth Downey as they guide you through the key elements of a comprehensive IP strategy, including licences and agreements. They’ll share insights on the essential components of an IP strategy for the healthcare sector and discuss how these components vary based on the type of innovation—whether in biotech, pharma, or digital health—and the intended business model.
